HomeAbout

TL;DR CNBC


The pet drugs vets are now prescribing look a lot more like human medications - TL;DR CNBC

The pet drugs vets are now prescribing look a lot more like human medications

Publishing timestamp: 2024-02-28 11:52:26


Summary

Zoetis is leading the way in bridging the gap between human and animal health products, with a focus on innovative treatments for pets such as the first monoclonal antibody pain treatment for cats and dogs. The company is also investing in genetics and AI technology to improve diagnostics and quality of life for animals.


Sentiment: POSITIVE

Tickers: AZNPFENOVO.B-DKZTSLLYAZN-GBNVO

Keywords: veterinarianhealth care industryweight managementanimal healthbusiness newspharmaceuticalspfizer incdrug trialsastrazeneca plcpharmaceutical industry regulationzoetis incdogseli lilly and coanimalscatspetsdiabetesnovo nordisk a/shealth insurance

Source: https://www.cnbc.com/2024/02/28/new-pet-drugs-are-looking-a-lot-more-like-human-medications.html


Developed by Leo Phan